TNFRSF17 and plasma cell myeloma: The clonal heterogeneity, genomic instability, and high propensity for antigen escape (e.g., BCMA downregulation) intrinsic to myeloma are not merely challenges of persistence, but fundamental drivers of relapse that demand a more sustained and potent effector response.